Dolan Christine 4

What Happened
Christine Dolan, Executive Vice President & General Manager, Cygnus Technologies at Maravai LifeSciences (MRVI), acquired 5,006 shares of Maravai Class A common stock on 2026-05-15. The shares were purchased under the company’s 2020 Employee Stock Purchase Plan at $1.79 per share for a total of $8,961. This was an acquisition (purchase/award) rather than a sale.

Key Details

• Transaction date: 2026-05-15; Price: $1.79 per share; Shares acquired: 5,006; Total value: $8,961.
• Purchase was made under the Maravai 2020 Employee Stock Purchase Plan (ESPP).
• Footnote: The acquisition was reported as exempt under Rule 16b-3 (per the filing).
• Shares owned after the transaction: not specified in this Form 4 filing.
• Filing date: 2026-05-22 (the Form 4 was filed seven days after the transaction), which is later than the typical 2-business-day filing deadline for Form 4s.

Context
This was a purchase via an employee plan (ESPP) — a routine way for employees to acquire company stock. The amount is modest (~$9k); such purchases can be interpreted as mildly positive but are not a definitive signal of broader insider sentiment. No options were exercised and no sales were reported in this filing.